Literature DB >> 18645090

Long-term results of carbon dioxide laser resurfacing of the face.

P Daniel Ward1, Shan R Baker.   

Abstract

OBJECTIVE: To evaluate the long-term effectiveness of, and the complications associated with, carbon dioxide laser treatment of rhytidosis and solar aging.
METHODS: This retrospective report describes our experience with 47 patients who underwent entire facial carbon dioxide laser resurfacing.
RESULTS: The mean improvement in facial rhytid score at long-term follow-up was 45%. This improvement was consistent in all facial subsites. With the exception of 1 case of hyperpigmentation, which resolved within 2 years of treatment, hypopigmentation was the only long-term adverse effect. This complication was present in 6 patients (13%). The patients who developed hypopigmentation were more likely to have a greater response to treatment.
CONCLUSION: Our findings show that carbon dioxide laser resurfacing is a safe and effective treatment for facial rhytids.

Entities:  

Mesh:

Year:  2008        PMID: 18645090     DOI: 10.1001/archfaci.10.4.238

Source DB:  PubMed          Journal:  Arch Facial Plast Surg        ISSN: 1521-2491


  4 in total

1.  Current Laser Resurfacing Technologies: A Review that Delves Beneath the Surface.

Authors:  Jason Preissig; Kristy Hamilton; Ramsey Markus
Journal:  Semin Plast Surg       Date:  2012-08       Impact factor: 2.314

2.  Fractional CO2 Laser Resurfacing Complications.

Authors:  William M Ramsdell
Journal:  Semin Plast Surg       Date:  2012-08       Impact factor: 2.314

3.  A Prospective Study Evaluating the Use of Helium Plasma for Dermal Resurfacing.

Authors:  J David Holcomb; Michael Kelly; Tiffani K Hamilton; Joseph B DeLozier
Journal:  Lasers Surg Med       Date:  2020-04-29       Impact factor: 4.025

4.  Safety and efficacy of fractional radiofrequency for the treatment and reduction of acne scarring: A prospective study.

Authors:  Stephen W Eubanks; James A Solomon
Journal:  Lasers Surg Med       Date:  2021-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.